These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28899763)

  • 1. Provoking an end-to-end continuous direct compression line with raw materials prone to segregation.
    Lakio S; Ervasti T; Tajarobi P; Wikström H; Fransson M; Karttunen AP; Ketolainen J; Folestad S; Abrahmsén-Alami S; Korhonen O
    Eur J Pharm Sci; 2017 Nov; 109():514-524. PubMed ID: 28899763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between integrated continuous direct compression line and batch processing - The effect of raw material properties.
    Karttunen AP; Wikström H; Tajarobi P; Fransson M; Sparén A; Marucci M; Ketolainen J; Folestad S; Korhonen O; Abrahmsén-Alami S
    Eur J Pharm Sci; 2019 May; 133():40-53. PubMed ID: 30862514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous direct tablet compression: effects of impeller rotation rate, total feed rate and drug content on the tablet properties and drug release.
    Järvinen MA; Paaso J; Paavola M; Leiviskä K; Juuti M; Muzzio F; Järvinen K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1802-8. PubMed ID: 23163644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
    Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
    Chattoraj S; Sun CC
    J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
    Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
    Ervasti T; Simonaho SP; Ketolainen J; Forsberg P; Fransson M; Wikström H; Folestad S; Lakio S; Tajarobi P; Abrahmsén-Alami S
    Int J Pharm; 2015 Nov; 495(1):290-301. PubMed ID: 26320548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study.
    Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J
    Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
    Hirschberg C; Sun CC; Rantanen J
    J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lubricant based determination of design space for continuously manufactured high dose paracetamol tablets.
    Taipale-Kovalainen K; Karttunen AP; Ketolainen J; Korhonen O
    Eur J Pharm Sci; 2018 Mar; 115():1-10. PubMed ID: 29277668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a continuous direct compression platform for low-dose drug products.
    Van Snick B; Holman J; Vanhoorne V; Kumar A; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Aug; 529(1-2):329-346. PubMed ID: 28684361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic development of a high dosage formulation to enable direct compression of a poorly flowing API: A case study.
    Schaller BE; Moroney KM; Castro-Dominguez B; Cronin P; Belen-Girona J; Ruane P; Croker DM; Walker GM
    Int J Pharm; 2019 Jul; 566():615-630. PubMed ID: 31158454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow, Particle Size, and Tooling Dimension.
    Zhao J; Yin D; Rowe J; Badawy S; Nikfar F; Pandey P
    J Pharm Sci; 2018 Apr; 107(4):1204-1208. PubMed ID: 29233726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets.
    Lyytikäinen J; Stasiak P; Kubelka T; Olenius T; Korhonen O; Ketolainen J; Ervasti T
    Int J Pharm; 2022 Nov; 628():122355. PubMed ID: 36341918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges encountered in the transfer of atorvastatin tablet manufacturing - commercial batch-based production as a basis for small-scale continuous tablet manufacturing tests.
    Lyytikäinen J; Kyllönen S; Ervasti T; Komulainen E; Pekarek T; Slunečková J; Leskinen J; Ketolainen J; Kubelka T; Stasiak P; Korhonen O
    Int J Pharm; 2023 Nov; 647():123509. PubMed ID: 37832703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Mixing Technology: Characterization of a Vertical Mixer Using Residence Time Distribution.
    Lee KT; Kimber JA; Cogoni G; Brandon JK; Wilsdon D; Verrier HM; Grieb S; Blackwood DO; Jain AC; Doshi P
    J Pharm Sci; 2021 Jul; 110(7):2694-2702. PubMed ID: 33607187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Effect of APAP Crystals on Tablet Behavior Manufactured by Direct Compression.
    Ghazi N; Liu Z; Bhatt C; Kiang S; Cuitino A
    AAPS PharmSciTech; 2019 Apr; 20(5):168. PubMed ID: 30993408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quality by design approach to investigate the effect of mannitol and dicalcium phosphate qualities on roll compaction.
    Souihi N; Dumarey M; Wikström H; Tajarobi P; Fransson M; Svensson O; Josefson M; Trygg J
    Int J Pharm; 2013 Apr; 447(1-2):47-61. PubMed ID: 23434544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.